These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study. Malanos D; Stern RS J Am Acad Dermatol; 2007 Aug; 57(2):231-7. PubMed ID: 17532094 [TBL] [Abstract][Full Text] [Related]
4. A retrospective study of ocular findings in patients treated with PUVA. Boukes RJ; van Balen AT; Bruynzeel DP Doc Ophthalmol; 1985 Jan; 59(1):11-9. PubMed ID: 3987491 [TBL] [Abstract][Full Text] [Related]
5. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation. Lafond G; Roy PE; Grenier R Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101 [TBL] [Abstract][Full Text] [Related]
6. PUVA therapy and the lens reconsidered. Van Deenen WL; Lamers WP Doc Ophthalmol; 1988; 70(2-3):179-83. PubMed ID: 3234182 [TBL] [Abstract][Full Text] [Related]
7. Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestations. Lerman S Natl Cancer Inst Monogr; 1984 Dec; 66():227-33. PubMed ID: 6531035 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211 [TBL] [Abstract][Full Text] [Related]
9. 8-methoxypsoralen and long ultraviolet effects on the rat lens: experiments with high dosage. Koch HR; Beitzen R; Kremer F; Chioralia G; Baurmann H; Megaw J; Gardner K; Lerman S Graefes Arch Clin Exp Ophthalmol; 1982; 218(4):193-9. PubMed ID: 7084696 [TBL] [Abstract][Full Text] [Related]
10. Ocular complications of PUVA therapy. See JA; Weller P Australas J Dermatol; 1993; 34(1):1-4. PubMed ID: 8240180 [TBL] [Abstract][Full Text] [Related]
12. A retrospective study of cataract formation in 96 patients treated with PUVA. Hammershøy O; Jessen F Acta Derm Venereol; 1982; 62(5):444-6. PubMed ID: 6183901 [TBL] [Abstract][Full Text] [Related]
13. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. Stern RS; Bagheri S; Nichols K; J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578 [TBL] [Abstract][Full Text] [Related]
14. Psoralens and ocular effects in humans. Glew WB; Nigra TP Natl Cancer Inst Monogr; 1984 Dec; 66():235-9. PubMed ID: 6531036 [TBL] [Abstract][Full Text] [Related]
15. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient. Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825 [TBL] [Abstract][Full Text] [Related]
16. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595 [TBL] [Abstract][Full Text] [Related]